Yes, The FDA Is In Trouble, But The New York Times’ Prescription Would Make It Worse

The FDA’s failures are a result of too much regulatory dithering and bureaucracy. Yet the Times’ prescriptions for change would just increase the dose.

Komentar

Postingan populer dari blog ini

House GOP Demands ActBlue Forfeit Info About ‘Unserious’ Efforts To Stop Foreign Donations